SEARCH HEALTH CONDITIONS BY ALPHABETS
Lipoatrophy, Facial
Medications for Facial Lipoatrophy
Other titles: Facial Weight Loss; Facial Wasting; Lipoatrophy, Facial
About Facial Lipoatrophy: Facial Lipoatrophy is the reduction of subcutaneous fat onto the surface .
Drugs Used to Treat Facial Lipoatrophy
This list of medications have been utilized at the treatment of this particular condition, or in some way associated with.
Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
Sculptra | Rx | N | N | Insert inspection | 0.0 | ||
Generic name: poly-l-lactic acid systemic Medication course: amalgamated uncategorized agents For customers: | |||||||
poly-l-lactic acid | Rx | N | N | Insert inspection | 0.0 | ||
Generic name: poly-l-lactic acid systemic Brand name: Sculptra Medication course: amalgamated uncategorized agents For customers: For professionals: az Drug Facts | |||||||
Legend
Rx | prescription-only |
---|---|
OTC | On The Counter |
Rx/OTC | Prescription or Over The Counter |
Away Tag | This medication may not be approved by the FDA for the treatment of the particular condition. |
Pregnancy Category | |
---|---|
A | sufficient and well-controlled studies have failed to present a risk to the fetus in the first trimester of pregnancy (also there isn`t any evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown a negative effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in used in pregnant women obviously outweigh potential gains. |
N | FDA have not classified this drug. |
Controlled Substances Act (CSA) Program | |
---|---|
N | Is not at the mercy of the Controlled Substances Act. |
Inch | Has a high potential for misuse. Has no accepted medical use in treatment in the United States. There`s a lack of accepted safety for use under medical supervision. |
Two | Has a high potential for misuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may cause acute psychological or physical dependency. |
3 | Has a potential for abuse less than those in programs 1 and two. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a very low potential for abuse in accordance with those in schedule 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a very low potential for abuse in accordance with those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Ep
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always consult with your physician to ensure the information displayed on these pages applies to your circumstances.
Product Categories